ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment. - Steimle JD; Kim C; Rowton M; Nadadur RD; Wang Z; Stocker M; Hoffmann AD; Hanson E; Kweon J; Sinha T; Choi K; Black BL; et al. (Cell reports, 2023)